Skip to main content
Industry News
Moderna's COVID-19 vaccine moves toward midstage trials

Moderna chairman Noubar Afeyan said the company's COVID-19 vaccine candidate could enter midstage trials by spring or early summer. The vaccine started Phase I trials last month, and Moderna is already ramping up manufacturing capacity to allow production of millions of doses if the vaccine proves safe and effective.

Full Story: